CD8A and chronic obstructive pulmonary disease: The combination of Salmeterol and Fluticasone exerts significant effects in patients with COPD, improving lung function, elevating CD4 + counts and the CD4+/CD8 + ratio, reducing CD8 + levels, and producing minimal changes in the oropharyngeal microflora [10].